The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretmm

被引:2
作者
Sahin, Nurhan [1 ]
Akatli, Ayse Nur [1 ]
Celik, Muhammet Reha [2 ]
Ulutas, Hakki [2 ]
Samdanci, Emine Turkmen [1 ]
Colak, Cemil [3 ]
机构
[1] Inonu Univ, Dept Pathol, Turgut Ozal Med Ctr, TR-44280 Malatya, Turkey
[2] Inonu Univ, Dept Thorac Surg, Turgut Ozal Med Ctr, Malatya, Turkey
[3] Inonu Univ, Fac Med, Dept Biostat, Malatya, Turkey
关键词
Mesothelioma; CD; 90; Pulmonary adenocarcinoma; Squamous cell carcinoma; EPITHELIOID MESOTHELIOMA; LUNG-CARCINOMA; EXPRESSION; MARKERS; IDENTIFICATION; ADENOCARCINOMA; CAVEOLIN-1; UTILITY;
D O I
10.1007/s12253-016-0135-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pleural Malignant Mesothelioma (MM) is a fatal disease that has been associated with asbestos exposure. Differential diagnosis between the pleural infiltration of pulmonary carcinomas and MM is rather difficult particularly for epitheloid type mesothelioma. We aimed to investigate the utility of CD90, a cancer stem cell marker, in the differential diagnosis of MM and lung carcinoma, its prognostic significance and compare its value with that of Calretinin. Ninety pathology specimens including MM (n:30), pulmonary adenocarcinoma (n:30) and pulmonary squamous cell carcinoma (n:30) were used in this study. Immunohistochemical comparision of CD 90 and Calretinin was made in all groups. Calretinin was positive in 20 cases with MM (64.5 %), and was negative in 10 (32.3 %). CD 90 was positive in 25 of these cases (80 %) and negative in 5 (16 %). On the other hand pulmonary adenocarcinomas and squamous cell carcinomas showed positivity with CD90, 63,6 % and 73 %, respectively. We think that CD 90 has no place in the differential diagnosis between mesothelioma and pulmonary carcinoma because of the low specificity in spite of the high sensitivity.
引用
收藏
页码:487 / 491
页数:5
相关论文
共 17 条
[1]   Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma [J].
Amatya, Vishwa Jeet ;
Takeshima, Yukio ;
Kohno, Hidekazu ;
Kushitani, Kei ;
Yamada, Taketo ;
Morimoto, Chikao ;
Inai, Kouki .
HISTOPATHOLOGY, 2009, 55 (01) :10-19
[2]  
[Anonymous], CANC TREAT REV
[3]   Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines [J].
Ascoli, Valeria .
ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2015, 51 (01) :52-59
[4]   Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases [J].
Cassoni, Paola ;
Daniele, Lorenzo ;
Maldi, Elena ;
Righi, Luisella ;
Tavaglione, Veronica ;
Novello, Silvia ;
Volante, Marco ;
Scagliotti, Giorgio Vittorio ;
Papotti, Mauro .
HISTOPATHOLOGY, 2009, 55 (01) :20-27
[5]   Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma [J].
Chaouche-Mazouni, Siham ;
Scherpereel, Arnaud ;
Zaamoum, Rima ;
Mihalache, Adriana ;
Arnir, Zine-Charaf ;
Lebaili, Nemcha ;
Delaire, Baptiste ;
Gosset, Pierre .
ANNALS OF DIAGNOSTIC PATHOLOGY, 2015, 19 (04) :193-197
[6]   Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations? [J].
Deniz, Hale ;
Kibar, Yasemin ;
Guldur, Muhammet Emin ;
Bakir, Kemal .
PATHOLOGY RESEARCH AND PRACTICE, 2009, 205 (11) :749-752
[7]   Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma [J].
Gueugnon, Fabien ;
Leclercq, Sabrina ;
Blanquart, Christophe ;
Sagan, Christine ;
Cellerin, Laurent ;
Padieu, Martine ;
Perigaud, Christian ;
Scherpereel, Arnaud ;
Gregoire, Marc .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (03) :1033-1042
[8]   Cancer stem cells in solid tumors [J].
Hermann, Patrick C. ;
Bhaskar, Sonu ;
Cioffi, Michele ;
Heeschen, Christopher .
SEMINARS IN CANCER BIOLOGY, 2010, 20 (02) :77-84
[9]   Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma [J].
Ji, Junfang ;
Wang, Xin Wei .
SEMINARS IN ONCOLOGY, 2012, 39 (04) :461-472
[10]   CD90 Is a Diagnostic Marker to Differentiate Between Malignant Pleural Mesothelioma and Lung Carcinoma With Immunohistochemistry [J].
Kawamura, Kiyoko ;
Hiroshima, Kenzo ;
Suzuki, Takeo ;
Chai, Kuan ;
Yamaguchi, Naoto ;
Shingyoji, Masato ;
Yusa, Toshikazu ;
Tada, Yuji ;
Takiguchi, Yuichi ;
Tatsumi, Koichiro ;
Shimada, Hideaki ;
Tagawa, Masatoshi .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (04) :544-549